Top Markets
#1 Black Phoenix Black Phoenix +732.61%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.20%
#3 MiL.k Alliance MiL.k Alliance +23.48%
#4 Biconomy Biconomy +23.13%
#5 THORChain THORChain +19.17%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +15.80%
#7 MetaDAO MetaDAO +14.29%
#8 THORChain Yield THORChain Yield +14.24%
#9 Moolah Moolah +13.56%
#10 XPIN Network XPIN Network +12.67%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Pell Bio-Med Technology Co., Ltd. Pell Bio-Med Technology Co., Ltd.

Pell Bio-Med Technology Co., Ltd.

6949
Clasificación en acciones #4991
Pell Bio-Med Technology Co., Ltd., established in 2017 and headquartered in... Pell Bio-Med Technology Co., Ltd., established in 2017 and headquartered in Taipei, Taiwan, operates as a biomedical firm specializing in advanced cell culture technologies and methods for therapeutic applications. The company's commercial portfolio encompasses good tissue practice (GTP) laboratory infrastructure, adipose-derived stem cells (ADSC) utilized in regenerative medicine, and both CIK and DC-CIK therapies aimed at combating various cancers. Beyond its existing products, Pell Bio-Med is actively engaged in developing novel pharmaceuticals for diverse cancer types, pioneering cell immunotherapy strategies, and advancing stem cell regenerative therapy techniques. Its research and development efforts extend to cutting-edge areas such as chimeric antigen receptor T cell (CAR-T), CAR-NK, CAR-?dT, and genetically modified ADSC technologies. The company is also progressing product development specifically targeting indications like B-cell non-Hodgkin lymphoma (B-NHL), ovarian cancer, multiple myeloma, and thyroid cancer.
Precio por acción
$47.38
Última sincronización: 2026-08-26
Capitalización bursátil
$3.11B
Cambio (1 día)
9.96%
Cambio (1 año)
238.59%
País
TW
Comercio Pell Bio-Med Technology Co., Ltd. (6949)

Categoría

Healthcare
Historial del precio de la acción de Pell Bio-Med Technology Co., Ltd. (6949)
Precio más alto de cierre: $35.36 el 2026-08-01

Precio más bajo de cierre: $2.71 el 2024-03-01
Historial del precio de la acción de Pell Bio-Med Technology Co., Ltd. desde 2024 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 64.40%
2025 354.23%
2024 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.75%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.35 491.02%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.52 -12.73%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 7.08%
CH